Retrovirus-Mediated Suicide Gene Transduction in the Vitreous Cavity of the Eye: Feasibility in Prevention of Proliferative Vitreoretinopathy
Authors:
- Taiji SakamotoTSTaiji Sakamoto
- Jose A. CardilloJCJose A. Cardillo
- Christine SpeeCSChristine Spee
- David R. HintonDHDavid R. Hinton
- Erlinda M. GordonEGErlinda M. Gordon
- W. French AndersonWAW. French Anderson
- Stephen J. RyanSRStephen J. Ryan
- 1 May 1996
- journal article
- research article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 7 (7) , 799-808
Abstract
In proliferative vitreoretinopathy (PVR), retinal pigment epithelial cells, fibroblasts, or other proliferating cells form contractile membranes in the vitreous cavity of the eye, resulting in traction retinal detachment. Retroviral vector-mediated transfer is a suitable method to transduce the herpes simplex virus thymidine kinase (HSV-tk) gene into proliferating cells in PVR, allowing for the selective killing of these cells. To determine the potential of gene transduction in the environment of the vitreous cavity, we evaluated the effect of vitreous humor on retroviral vector-mediated gene transduction of rabbit dermal fibroblasts in vitro and studied in vivo transduction in rabbit experimental PVR with retroviral vector G1BgSvNa. In addition, we studied the bystander effect in vitro and in vivo in a rabbit model of PVR, with low percentages of HSV-tk-positive cells. Finally, we evaluated the efficacy of intravitreal administration of HSV-tk retroviral vector G1TkSvNa followed by ganciclovir (GCV) in the prevention of experimental PVR. Vitreous humor reduced gene transfer efficiency in vitro in a dose-dependent manner. LacZ expression was found in cells of preretinal or intravitreal membranes of animals of both in vivo and in vitro transduction groups; however, in vivo transduction resulted in a decreased number of transduced cells, with a relative transduction efficiency of approximately 2%. Transduction of HSV-tk was associated with a powerful bystander effect both in vitro and in vivo with significant effects even when HSV-tk-positive cells represented only 1% of the population. In vivo transduction with G1TkSvNa followed by GCV significantly inhibited the development of PVR (p < 0.05). These results suggest that retroviral vector-mediated transfer of HSV-tk into the proliferating cells in PVR may be feasible and may provide a novel therapeutic strategy for this disease. Retroviral vector-mediated transfer of the herpes simplex virus thymidine kinase (HSV-tk) gene is a novel strategy to treat proliferative vitreoretinopathy (PVR). For clinical application of this therapy, we evaluated the effect of vitreous on retroviral vector-mediated gene transfer efficiency in vitro and studied in vivo gene transfer in a rabbit PVR model with retroviral vector G1BgSvNa. In addition, we studied the bystander effect in this therapy because in vivo transduction efficiency with retroviral vectors is generally low. Finally, we evaluated the efficacy of in vivo transduction with HSV-tk retroviral vector G1TkSvNa followed by ganciclovir (GCV) in the prevention of experimental PVR. The vitreous inhibited gene transfer efficiency in vitro in a dose-dependent manner. The relative in vivo transduction efficiency was approximately 2%. Low-level expression of the HSV-tk gene (1–10%) resulted in a bystander effect after GCV treatment in vitro and in vivo. In vivo transduction with G1TkSvNa followed by GCV significantly inhibited PVR (p < 0.05). These results suggest that retroviral vector-mediated transfer of the HSV-tk gene is a feasible strategy for the prevention of PVR.Keywords
This publication has 28 references indexed in Scilit:
- Bystander Tumoricidal Effect in the Treatment of Experimental Brain TumorsNeurosurgery, 1994
- The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in ratsJournal of Neurosurgery, 1994
- ADENOVIRUS-MEDIATED GENE TRANSFER IN THE TRANSPLANT SETTINGTransplantation, 1994
- Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus VectorsHuman Gene Therapy, 1994
- In Vitro Evidence That Metabolic Cooperation Is Responsible for the Bystander Effect Observed with HSV tk Retroviral Gene TherapyHuman Gene Therapy, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTTJournal of Immunological Methods, 1991
- In Vivo Expression and Survival of Gene-Modified T Lymphocytes in Rhesus MonkeysHuman Gene Therapy, 1990
- Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase TransgeneHuman Gene Therapy, 1990
- Vitreous stimulates proliferation of fibroblasts and retinal pigment epithelial cellsExperimental Eye Research, 1985